249 related articles for article (PubMed ID: 38055419)
1. End-to-end validation of fiducial tracking accuracy in robotic radiosurgery using MRI-only simulation imaging.
Singhrao K; Zubair M; Nano T; Scholey JE; Descovich M
Med Phys; 2024 Jan; 51(1):31-41. PubMed ID: 38055419
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers.
Goudschaal K; Beeksma F; Boon M; Bijveld M; Visser J; Hinnen K; van Kesteren Z
Radiat Oncol; 2021 Feb; 16(1):37. PubMed ID: 33608008
[TBL] [Abstract][Full Text] [Related]
3. Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation.
Singhrao K; Ruan D; Fu J; Gao Y; Chee G; Yang Y; King C; Hu P; Kishan AU; Lewis JH
Phys Med Biol; 2020 Feb; 65(3):035015. PubMed ID: 31881546
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
Koivula L; Wee L; Korhonen J
Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the Hounsfield unit assignment and dose differences between CT-based standard and deep learning-based synthetic CT images for MRI-only radiation therapy of the head and neck.
Singhrao K; Dugan CL; Calvin C; Pelayo L; Yom SS; Chan JW; Scholey JE; Singer L
J Appl Clin Med Phys; 2024 Jan; 25(1):e14239. PubMed ID: 38128040
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.
Maspero M; Seevinck PR; Willems NJW; Sikkes GG; de Kogel GJ; de Boer HCJ; van der Voort van Zyp JRN; van den Berg CAT
Radiat Oncol; 2018 Jun; 13(1):105. PubMed ID: 29871656
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an automatic MR-based gold fiducial marker localisation method for MR-only prostate radiotherapy.
Maspero M; van den Berg CAT; Zijlstra F; Sikkes GG; de Boer HCJ; Meijer GJ; Kerkmeijer LGW; Viergever MA; Lagendijk JJW; Seevinck PR
Phys Med Biol; 2017 Oct; 62(20):7981-8002. PubMed ID: 28825917
[TBL] [Abstract][Full Text] [Related]
8. A multi-institutional analysis of a general pelvis continuous Hounsfield unit synthetic CT software for radiotherapy.
Yu VY; Keyrilainen J; Suilamo S; Beslimane I; Dresner A; Halkola A; Van der Heide UA; Tyagi N
J Appl Clin Med Phys; 2021 Mar; 22(3):207-215. PubMed ID: 33616303
[TBL] [Abstract][Full Text] [Related]
9. A novel anthropomorphic multimodality phantom for MRI-based radiotherapy quality assurance testing.
Singhrao K; Fu J; Wu HH; Hu P; Kishan AU; Chin RK; Lewis JH
Med Phys; 2020 Apr; 47(4):1443-1451. PubMed ID: 31954078
[TBL] [Abstract][Full Text] [Related]
10. Synthetic digital reconstructed radiographs for MR-only robotic stereotactic radiation therapy: A proof of concept.
Szalkowski G; Nie D; Zhu T; Yap PT; Lian J
Comput Biol Med; 2021 Nov; 138():104917. PubMed ID: 34688037
[TBL] [Abstract][Full Text] [Related]
11. A generative adversarial network-based (GAN-based) architecture for automatic fiducial marker detection in prostate MRI-only radiotherapy simulation images.
Singhrao K; Fu J; Parikh NR; Mikaeilian AG; Ruan D; Kishan AU; Lewis JH
Med Phys; 2020 Dec; 47(12):6405-6413. PubMed ID: 32989773
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric and workflow evaluation of first commercial synthetic CT software for clinical use in pelvis.
Tyagi N; Fontenla S; Zhang J; Cloutier M; Kadbi M; Mechalakos J; Zelefsky M; Deasy J; Hunt M
Phys Med Biol; 2017 Apr; 62(8):2961-2975. PubMed ID: 27983520
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T
Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
[TBL] [Abstract][Full Text] [Related]
14. Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging.
Osman SOS; Russell E; King RB; Crowther K; Jain S; McGrath C; Hounsell AR; Prise KM; McGarry CK
Radiat Oncol; 2019 Dec; 14(1):237. PubMed ID: 31878967
[TBL] [Abstract][Full Text] [Related]
15. Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI Sequences.
Dowling JA; Sun J; Pichler P; Rivest-Hénault D; Ghose S; Richardson H; Wratten C; Martin J; Arm J; Best L; Chandra SS; Fripp J; Menk FW; Greer PB
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1144-53. PubMed ID: 26581150
[TBL] [Abstract][Full Text] [Related]
16. Utilizing the TrueBeam Advanced Imaging Package to monitor intrafraction motion with periodic kV imaging and automatic marker detection during VMAT prostate treatments.
Korpics MC; Rokni M; Degnan M; Aydogan B; Liauw SL; Redler G
J Appl Clin Med Phys; 2020 Mar; 21(3):184-191. PubMed ID: 31981305
[TBL] [Abstract][Full Text] [Related]
17. On the total system error of a robotic radiosurgery system: phantom measurements, clinical evaluation and long-term analysis.
Pantelis E; Moutsatsos A; Antypas C; Zoros E; Pantelakos P; Lekas L; Romanelli P; Zourari K; Hourdakis CJ
Phys Med Biol; 2018 Aug; 63(16):165015. PubMed ID: 30033940
[TBL] [Abstract][Full Text] [Related]
18. Automated target tracking in kilovoltage images using dynamic templates of fiducial marker clusters.
Campbell WG; Miften M; Jones BL
Med Phys; 2017 Feb; 44(2):364-374. PubMed ID: 28035655
[TBL] [Abstract][Full Text] [Related]
19. MRI-alone radiation therapy planning for prostate cancer: Automatic fiducial marker detection.
Ghose S; Mitra J; Rivest-Hénault D; Fazlollahi A; Stanwell P; Pichler P; Sun J; Fripp J; Greer PB; Dowling JA
Med Phys; 2016 May; 43(5):2218. PubMed ID: 27147334
[TBL] [Abstract][Full Text] [Related]
20. Fiducial marker based intra-fraction motion assessment on cine-MR for MR-linac treatment of prostate cancer.
de Muinck Keizer DM; Pathmanathan AU; Andreychenko A; Kerkmeijer LGW; van der Voort van Zyp JRN; Tree AC; van den Berg CAT; de Boer JCJ
Phys Med Biol; 2019 Apr; 64(7):07NT02. PubMed ID: 30794995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
